Overview
Tamir Shragai practices in Tel Aviv, Israel. Mr. Shragai is rated as an Advanced expert by MediFind in the treatment of Multiple Myeloma. His top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Plasmacytoma, and Smoldering Multiple Myeloma.
His clinical research consists of co-authoring 16 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Multiple Myeloma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Multiple MyelomaMr. Shragai isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Cardiac AmyloidosisMr. Shragai isExperienced. Learn about Cardiac Amyloidosis.
- Cytomegalic Inclusion DiseaseMr. Shragai isExperienced. Learn about Cytomegalic Inclusion Disease.
- Cytomegalovirus InfectionMr. Shragai isExperienced. Learn about Cytomegalovirus Infection.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- PlasmacytomaMr. Shragai isExperienced. Learn about Plasmacytoma.
- Primary AmyloidosisMr. Shragai isExperienced. Learn about Primary Amyloidosis.